18 Biggest Mid-Day Gainers For Monday

Corbus Pharmaceuticals Holdings Inc CRBP shares climbed 68.8 percent to $9.88 after the company reported positive top line results from its second stage trial of Resunab (JBT-101) for systemic sclerosis treatment.
DryShips Inc. DRYS shares surged 64 percent to $22.30. DryShips shares have tumbled 94.67 percent over the past 52 weeks, while the S&P 500 index has increased 5.42 percent in the same period.
Eagle Bulk Shipping Inc EGLE shares rose 27.3 percent to $7.74. Eagle Bulk Shipping shares have dropped 91.89 percent over the past 52 weeks, while the S&P 500 index has gained 5.42 percent in the same period.
Harman International Industries Inc HAR shares surged 25.4 percent to $109.90 after Samsung Electronics announced plans to buy the company in an $8 billion deal.
Mentor Graphics Corp MENT shares jumped 18.8 percent to $36.46 after Siemens announced plans to acquire the company for $37.25 per share in cash.
Ocean Bio-Chem, Inc. OBCI shares surged 18.1 percent to $3.39. Ocean Bio-Chem reported Q3 earnings of $0.17 per share on revenue of $12.207 million.
Mechel PAO (ADR) MTL shares jumped 18 percent to $6.43 after dropping 3.20 percent on Friday. Mechel reported its participation in the 22nd International Industrial Exhibition Metal-Expo held on November 8-11, 2016.
Amaya Inc. AYA shares climbed 15.6 percent to $15.73. Amaya posted upbeat Q3 earnings and issued a strong FY16 earnings forecast. Amaya’s former CEO, David Baazov, offered to acquire the company in a deal valued at around C$3.48 billion, or $2.56 billion.
Eleven Biotherapeutics Inc EBIO gained 15.3 percent to $3.02. Eleven Biotherapeutics posted Q3 earnings of $0.91 per diluted share on revenue of $28.65 million.
Digi International Inc. DGII gained 12.9 percent to $13.15. Belden Inc. BDC proposed to buy Digi International for $13.82 per share. However, Digi International’s board confirmed the rejection of proposal from Belden.
Ocular Therapeutix Inc OCUL shares surged 12.7 percent to $7.74 positive topline results from a Phase 3 clinical trial of Dextenza that met primary endpoints for inflammation and pain primary efficacy.
PTC Therapeutics, Inc. PTCT gained 8.9 percent to $12.30. Credit Suisse upgraded PTC Therapeutics from Neutral to Outperform and raised the price target from $15.00 to $25.00.
Chico's FAS, Inc. CHS shares jumped 7.5 percent to $14.73. Citigroup upgraded Chico's FAS from Neutral to Buy.
Kohl's Corporation KSS rose 7.1 percent to $57.01. Citigroup upgraded Kohl's from Neutral to Buy.
Regions Financial Corp RF gained 6.8 percent to $13.30. FBR Capital upgraded Regions Financial from Market Perform to Outperform.
AK Steel Holding Corporation AKS shares gained 6.7 percent to $8.00. Morgan Stanley upgraded AK Steel from Equal-Weight to Overweight and raised the price target from $5.00 to $11.00.
Quest Diagnostics Inc DGX rose 4.7 percent to $85.25. UBS upgraded Quest Diagnostics from Neutral to Buy.
Credit Suisse Group AG (ADR) CS gained 3.3 percent to $14.69. Bank of America upgraded Credit Suisse from Neutral to Buy.

Market News and Data brought to you by Benzinga APIs